European pharmaceutical stock linked ELN Currently we see demand in ELNs that are linked to European pharmaceutical stocks. This allows clients to enjoy a better risk versus reward through a combination of auto-callable levels with a conditional coupon at a different level and a conditional protection on the downside (European knock-in). The client can comfortably look for a higher yield…

To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].

Subscriber Only Content

This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.

Login

Subscribe

Indispensable intelligence

Request for a free trial to Asian Private Banker today.

Need help? Please see our FAQ Guide or email [email protected]